EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Efficacy of Upadacitinib in refractory Polyarteritis Nodosa: a case report

Akihiko Nakabayashi iD, Erika Iguchi, Dong Seop Kim, Yanakawee Siripongvutikorn, Akira Nishigaichi, Maiko Yoshimura, Hyota Takamatsu, Shiro Ohshima

Oxford Medical Case Reports · 22.02.2025 · 2025 (2)

DOI: 10.1093/omcr/omae199 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oxford Medical Case Reports, online erschienen am 22.02.2025. Verfasst von Akihiko Nakabayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, NHO Osaka Minami Medical Center, 2-1 Kidohigashi, Kawachinagano, Osaka 586-8521, Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyarteritis nodosa (PAN) is systemic vasculitis, typically treated with a combination of glucocorticoids and immunosuppressants. Changing the immunosuppressant is recommended if remission cannot be achieved with these treatments. However, there is a lack of further treatment options for patients who are unresponsive to all immunosuppressants. We report a 44-year-old Japanese man with refractory PAN who was unresponsive to various immunosuppressants (including tocilizumab). Upadacitinib treatment led to relatively rapid symptom improvement, allowing for tapering and eventual discontinuation of immunosuppressants, including prednisolone. During his 1-year follow-up, no relapse or side effects were noted. This case suggests that Janus kinase inhibitors may provide a breakthrough for patients with refractory PAN.

Schlagwörter

Stichwörter der Autor:innen

Janus kinase inhibitorsbiological therapycytokinespolyarteritis nodosasystemic vasculitistreatment failure

Autor:innen und Institutionen

  • Department of Rheumatology, NHO Osaka Minami Medical Center, 2-1 Kidohigashi, Kawachinagano, Osaka 586-8521, Japan.
  • Department of Clinical Research/Rheumatology, NHO Osaka Minami Medical Center, 2-1 Kidohigashi, Kawachinagano, Osaka 586-8521, Japan.
  • Department of Clinical Research, NHO Osaka Minami Medical Center, 2-1 Kidohigashi, Kawachinagano, Osaka 586-8521, Japan.

ORCID-Profile: Akihiko Nakabayashi

Zitieren

APA

Nakabayashi, A., Iguchi, E., Kim, D. S., Siripongvutikorn, Y., Nishigaichi, A., Yoshimura, M., Takamatsu, H., & Ohshima, S. (2025). Efficacy of Upadacitinib in refractory Polyarteritis Nodosa: a case report. Oxford Medical Case Reports, 2025(2). https://doi.org/10.1093/omcr/omae199

Vancouver

Nakabayashi A, Iguchi E, Kim DS, Siripongvutikorn Y, Nishigaichi A, Yoshimura M, et al. Efficacy of Upadacitinib in refractory Polyarteritis Nodosa: a case report. Oxford Medical Case Reports. 2025;2025(2). doi:10.1093/omcr/omae199

BibTeX
@article{Nakabayashi2025,
  author = {Nakabayashi, Akihiko and Iguchi, Erika and Kim, Dong Seop and Siripongvutikorn, Yanakawee and Nishigaichi, Akira and Yoshimura, Maiko and Takamatsu, Hyota and Ohshima, Shiro},
  title = {Efficacy of Upadacitinib in refractory Polyarteritis Nodosa: a case report},
  journal = {Oxford Medical Case Reports},
  year = {2025},
  volume = {2025},
  number = {2},
  doi = {10.1093/omcr/omae199}
}
Kostenlos starten →